Prostate Cancer Clinical Trial

Clinical Trial Finder Prostate Cancer Trials

ZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA)

See Locations Near You

Summary

This study is being carried out to see if ZD4054 (Zibotentan) is effective in treating prostate cancer and spread of cancer to the bone, and if so, how it compares with placebo (sugar pill). The study will also provide further information on the safety of ZD4054 (Zibotentan).

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Surgically or medically castrated
Bone metastasis
Rising PSA

Exclusion Criteria:

Opiate use
Prior chemotherapy

Study is for people with:

Prostate Cancer

Phase:

Phase 2

Estimated Enrollment:

447

Study ID:

NCT00090363

Recruitment Status:

Completed

Sponsor:

AstraZeneca

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Research Site
Tucson Arizona, , United States
Research Site
Los Angeles California, , United States
Research Site
Gainsville Florida, , United States
Research Site
Chicago Illinois, , United States
Research Site
Baltimore Maryland, , United States
Research Site
Cleveland Ohio, , United States
Research Site
Simpsonville South Carolina, , United States
Research Site
Wolloongabba Queensland, , Australia
Research Site
Ashford South Australia, , Australia
Research Site
Wodonga Victoria, , Australia
Research Site
Nedlands , , Australia
Research Site
Brussels , , Belgium
Research Site
Gent , , Belgium
Research Site
Leuven , , Belgium
Research site
Vancouver British Columbia, , Canada
Research site
London Ontario, , Canada
Research site
Toronto Ontario, , Canada
Research site
Montreal Quebec, , Canada
Research site
Quebec , , Canada
Research Site
Arhus , , Denmark
Research Site
Herlev , , Denmark
Research Site
Helsinki , , Finland
Research Site
Joensuu , , Finland
Research Site
OYS , , Finland
Research Site
Seinäjoki , , Finland
Research Site
Tampere , , Finland
Research Site
Lille , , France
Research Site
Montpellier , , France
Research Site
Paris , , France
Research site
Pontoise , , France
Research Site
Toulouse , , France
Research Site
Jakarta , , Indonesia
Research Site
Eindhoven , , Netherlands
Research Site
Groningen , , Netherlands
Research Site
Heerlen , , Netherlands
Research Site
Leiden , , Netherlands
Research Site
Rotterdam , , Netherlands
Research Site
Utrecht , , Netherlands
Research Site
Bergen , , Norway
Research Site
Fredrikstad , , Norway
Research Site
Moelv , , Norway
Research Site
Oslo , , Norway
Research Site
Tonsberg , , Norway
Research Site
Tromso , , Norway
Research Site
Trondheim , , Norway
Research Site
Bydgoszcz , , Poland
Research Site
Katowice , , Poland
Research Site
Warszawa , , Poland
Research Site
Goteborg , , Sweden
Research Site
Malmo , , Sweden
Research Site
Stockholm , , Sweden
Research Site
Geneve , , Switzerland
Research Site
Locarno , , Switzerland
Research Site
Birmingham , , United Kingdom
Research Site
Leeds , , United Kingdom
Research Site
London , , United Kingdom
Research Site
Maidstone , , United Kingdom
Research Site
Manchester , , United Kingdom
Research Site
Newcastle , , United Kingdom
Research Site
York , , United Kingdom

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Phase:

Phase 2

Estimated Enrollment:

447

Study ID:

NCT00090363

Recruitment Status:

Completed

Sponsor:


AstraZeneca

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
Clinical Trials Can be Life-Saving for Some
SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider